Parexel Early Phase Unit — Baltimore, Maryland

Parexel Early Phase Unit is a clinical research site located in Baltimore, Maryland, United States 21225.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Parexel Early Phase Unit has participated in 3 clinical trials.

Therapeutic areas: Healthy, Healthy Volunteers, Chemotherapy-induced Nausea and Vomiting.

Sponsors: Nivalis Therapeutics, Inc., Astellas Pharma Global Development, Inc., Tesaro, Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Parexel Early Phase Unit?

Parexel Early Phase Unit has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Parexel Early Phase Unit conducted?

Parexel Early Phase Unit has 3 clinical trials on record. Their work covers Healthy, Healthy Volunteers, Chemotherapy-induced Nausea and Vomiting.

Is Parexel Early Phase Unit accredited by Crixeo Health?

Parexel Early Phase Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Parexel Early Phase Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.